Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Retinopathy of prematurity.

W V Good1, R L Gendron

  • 1Smith Kettlewell Eye Research Institute, San Francisco, California, USA.

Ophthalmology Clinics of North America
|November 14, 2001
PubMed
Summary

Most cases of retinopathy of prematurity (ROP) resolve on their own. However, new treatments are required to prevent complications like retinal detachment and myopia, potentially by targeting molecular mechanisms.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Quantitative fiber tracking of the optic radiation is correlated with visual-evoked potential amplitude in preterm infants.

AJNR. American journal of neuroradiology·2010
Same author

Genomics and proteomics of retinopathy of prematurity: DNA-based prevention and treatment.

The British journal of ophthalmology·2007
Same author

The Early Treatment for Retinopathy of Prematurity Clinical Trial: presentation by subgroups versus analysis within subgroups.

The British journal of ophthalmology·2006
Same author

Retinopathy of prematurity.

The British journal of ophthalmology·2006
Same author

Periorbital haemangiomas.

The British journal of ophthalmology·2005
Same author

Retinopathy of prematurity's turning point.

The British journal of ophthalmology·2005

Area of Science:

  • Ophthalmology
  • Neonatology
  • Developmental Biology

Background:

  • Retinopathy of prematurity (ROP) is a significant cause of visual impairment in premature infants.
  • While many ROP cases spontaneously regress, some progress to severe stages, leading to vision loss.
  • Current treatments aim to halt ROP progression but have limitations and potential side effects.

Purpose of the Study:

  • To review the current understanding of ROP pathogenesis.
  • To highlight the need for improved therapeutic strategies beyond existing methods.
  • To explore the potential of targeting molecular pathways for novel ROP treatments.

Main Methods:

  • Literature review of spontaneous ROP regression.
  • Analysis of ROP progression and associated complications.
  • Exploration of molecular mechanisms implicated in ROP development and regression.

Main Results:

  • The majority of retinopathy of prematurity cases undergo spontaneous regression.
  • Significant need exists for advanced treatments to prevent severe outcomes like retinal detachment and myopia.
  • Molecular mechanisms represent a promising avenue for future ROP therapeutic development.

Conclusions:

  • While spontaneous regression is common, effective interventions are crucial for preventing long-term visual impairment.
  • Targeting specific molecular pathways offers a potential future direction for ROP treatment development.
  • Further research into the molecular underpinnings of ROP is warranted to develop innovative therapies.

Related Experiment Videos